Search Results

Catalia Health brings together artificial intelligence, psychology, and medicine to deliver lasting change. They create effective patient engagement and generate unique data of value to customers. The cloud-based platform delivers unique conversations to patients to help address their ongoing... More

APT is a mining-meets-agriculture company that is aiming to deeply disrupt the ~$20bn global potassium fertilizer (potash). Whereas potash is currently produced from rare salt mines buried deep in the earth at disparate locations, APT has a cost-effective patented technology of making this nutrient... More

Lightelligence develops optical chips for high-performance AI computing tasks. By processing information with light, our chips offer orders of magnitude improvement in terms of high speed, low latency, and low power consumption compared to traditional electronic architectures

Humatics advocates a human-centered vision of autonomy, where robots and other machines employ autonomous behaviors while appearing simple, predictable, and transparent to their human collaborators.

Humatics seeks to become the leading company enabling robots and autonomous systems to work... More

Immunai is an end-to-end computational immunology company leveraging the power of single-cell biology and AI to decode the Immune System to improve health and accelerate therapeutics.

Kebotix uses artificial intelligence and robotics towards the discovery, synthesis, and formulation of advanced materials and specialty chemicals.

Leela AI is a startup from the MIT ecosystem and a member of the STEX25 accelerator program at MIT Startup Exchange. Its Leela Platform is currently optimized for manufacturing operations that are not easily served by automation and IoT analytics, including environments with many human workers and... More

Syzygy Plasmonics is commercializing a radical new technology developed at Rice University. Our technology enables us to turn traditional catalysts into high efficiency photocatalysts. This conversion allows us to produce chemical reactors that are powered by light instead of burning fuel and... More

Asimov's technology is a synthetic biology CAD platform (Cello) that we developed at MIT to program living cells with "genetic circuits". We have used it to design the most complex sense-and-response cell behaviors to date. We are now extending the platform to build genetic control modules for cell... More